Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Borisy Alexis. Officer active across 8 companies, notably Blueprint Medicines Corp. In total, 24 disclosures have been recorded. History available since 2 June 2021. The latest transaction was disclosed on 26 June 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Borisy Alexis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Borisy Alexis is a declarant with 24 filings in total. In the recent filings tracked, the period runs from 2016-02-09 to 2026-06-23, with buy volume of EUR 0 and sell volume of EUR 0. He is a Director at Revolution Medicines, Inc., Blueprint Medicines Corp, Tango Therapeutics, Inc., Opko Health, INC. and Parabilis Medicines, Inc., and Executive Chairman at EQRx, Inc. The modal transaction nature is Attribution.